Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The wound healing effect of local leukocyte platelet-rich plasma after total hip arthroplasty: A randomized controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The zone model: A conceptual model for understanding the microenvironment of chronic wound infection

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Molecular and histological studies of bladder wound healing in a rodent model

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Consensus guidelines for the identification and treatment of biofilms in chronic nonhealing wounds

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The effect of honey-coated bandages compared with silver-coated bandages on treatment of malignant wounds-a randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma as a resuscitation fluid for volume-depleted shock: Potential benefits and risks

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. ABO blood types and sepsis mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Rapid wound closure is important after arthroplasty procedures to prevent postoperative complications. Platelets are rich in growth factors and leukocytes contribute to innate immunity. We hypothesized that topical leukocyte platelet-rich plasma (L-PRP) derived from the blood of patients would be beneficial to wound healing. In this randomized controlled trial, patients subjected to elective total hip arthroplasty (THA) were assigned by concealed allocation either L-PRP application onto the sutured fascia or no application (control) after the THA intervention. In addition, all patients received 1.5 g protein/kg, 5 g L-arginine, 500 mg vitamin C and 44 mg zinc daily over the 4-week postoperative period to obtain optimal nutrition. The primary endpoint was complete healing of the skin incision. The secondary endpoints were blood transfusions, length of hospital stay, pain and wound infections. Sixteen patients in the L-PRP group and 17 patients in the control group completed the trial. L-PRP treatment accelerated complete wound healing after 3 weeks (seven in the L-PRP group vs. zero in the control group, p = 0.003) and after 4 weeks (12 in the L-PRP group vs. six in the control group, p = 0.037). No postoperative superficial wound infections occurred within 4 weeks, and there were no significant differences in the other secondary outcomes. L-PRP generated in 10 sex-matched healthy volunteers revealed increased concentrations of platelets (5.8-fold) and leukocytes (2.3-fold) compared with those in whole blood. Furthermore, the concentration of keratinocyte mitogen epidermal growth factor in L-PRP (380 ± 130 pg/ml, mean ± SD) was higher (p < 0.001) than that in serum (130 ± 26 pg/ml). In conclusion, a single intraoperative local application of L-PRP promoted wound healing after THA, possibly mediated by EGF receptor agonists.

Original languageEnglish
JournalWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
Volume29
Issue number6
Pages (from-to)988-995
Number of pages8
ISSN1067-1927
DOIs
Publication statusPublished - Nov 2021

Bibliographical note

© 2021 The Wound Healing Society.

    Research areas

  • epithelialization, growth factors, postoperative complications, Vivostat platelet-rich fibrin

ID: 67843129